Market overview
The global urethral balloon catheters market is worth USD 1.4 bn in 2026 and is forecast to reach USD 2.1 bn by 2036, growing at a 4.3% CAGR. United States is the largest country market and Pure silicone is the largest by material segment.
| Scope | Indwelling catheters with a retention balloon placed through the urethra to drain the bladder: latex, silicone and antimicrobial-coated Foley catheters, including two-way and three-way types. |
|---|---|
| Industry | Healthcare |
| Value 2025 | USD 1.3 bn |
| Value 2026 | USD 1.4 bn |
| Value 2036 | USD 2.1 bn |
| CAGR 2026-2036 | 4.3% |
| Volume 2026 | 104 million units |
| Volume 2036 | 151 million units |
| Average price 2026 | USD 13.1 per unit |
| Report price | Starts from USD 1,999 |
| Published | November 2026 |
Request a free sample of this report
Urethral Balloon Catheters market size and forecast, 2026-2036
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Year | Market value |
|---|---|
| 2026 | USD 1.36 bn |
| 2027 | USD 1.42 bn |
| 2028 | USD 1.48 bn |
| 2029 | USD 1.54 bn |
| 2030 | USD 1.61 bn |
| 2031 | USD 1.68 bn |
| 2032 | USD 1.75 bn |
| 2033 | USD 1.82 bn |
| 2034 | USD 1.90 bn |
| 2035 | USD 1.98 bn |
| 2036 | USD 2.07 bn |
Urethral Balloon Catheters market segmentation
By material
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Coated latex | 38.0% | 31.6% | USD 516 mn | 2.4% |
| Pure silicone | 40.0% | 40.3% | USD 543 mn | 4.4% |
| Antimicrobial-coated | 22.0% | 28.1% | USD 299 mn | 6.9% |
By end use
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Hospitals | 70.0% | 67.0% | USD 951 mn | 3.8% |
| Long-term care | 16.0% | 16.8% | USD 217 mn | 4.8% |
| Home care | 14.0% | 16.2% | USD 190 mn | 5.8% |
By catheter
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Two-way | 60.0% | 58.0% | USD 815 mn | 4.0% |
| Three-way | 18.0% | 18.0% | USD 245 mn | 4.3% |
| Specialty | 22.0% | 24.0% | USD 299 mn | 5.2% |
By size
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Paediatric | 12.0% | 12.0% | USD 163 mn | 4.3% |
| Adult standard | 70.0% | 68.0% | USD 951 mn | 4.0% |
| Large irrigation | 18.0% | 20.0% | USD 245 mn | 5.4% |
By buyer
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Hospitals | 56.0% | 52.0% | USD 761 mn | 3.5% |
| Aged care homes | 26.0% | 26.0% | USD 353 mn | 4.3% |
| Retail and home | 18.0% | 22.0% | USD 245 mn | 6.4% |
Top 25 countries for urethral balloon catheters by revenue
Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 80.5% of 2026 revenue and the 25 countries below together hold 94.2%.
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| # | Country | Value 2026 | Share 2026 | Value 2036 | CAGR 2026-36 |
|---|---|---|---|---|---|
| 1 | United States | USD 408 mn | 30.0% | USD 569 mn | 3.4% |
| 2 | China | USD 190 mn | 14.0% | USD 354 mn | 6.4% |
| 3 | Germany | USD 82 mn | 6.0% | USD 114 mn | 3.4% |
| 4 | Japan | USD 82 mn | 6.0% | USD 108 mn | 2.8% |
| 5 | India | USD 68 mn | 5.0% | USD 145 mn | 7.9% |
| 6 | France | USD 61 mn | 4.5% | USD 85 mn | 3.3% |
| 7 | United Kingdom | USD 61 mn | 4.5% | USD 85 mn | 3.3% |
| 8 | Brazil | USD 54 mn | 4.0% | USD 87 mn | 4.8% |
| 9 | Italy | USD 48 mn | 3.5% | USD 66 mn | 3.4% |
| 10 | Russia | USD 41 mn | 3.0% | USD 56 mn | 3.2% |
| 11 | Spain | USD 40 mn | 2.9% | USD 54 mn | 3.2% |
| 12 | Mexico | USD 25 mn | 1.8% | USD 46 mn | 6.3% |
| 13 | Canada | USD 18 mn | 1.4% | USD 24 mn | 2.6% |
| 14 | Australia | USD 15 mn | 1.1% | USD 19 mn | 2.7% |
| 15 | Netherlands | USD 12 mn | 0.9% | USD 16 mn | 2.6% |
| 16 | Turkey | USD 11 mn | 0.8% | USD 20 mn | 6.3% |
| 17 | Poland | USD 9.7 mn | 0.7% | USD 18 mn | 6.4% |
| 18 | Saudi Arabia | USD 8.8 mn | 0.7% | USD 16 mn | 6.2% |
| 19 | South Korea | USD 8.0 mn | 0.6% | USD 10 mn | 2.6% |
| 20 | Belgium | USD 7.5 mn | 0.6% | USD 9.7 mn | 2.7% |
| 21 | Argentina | USD 6.9 mn | 0.5% | USD 13 mn | 6.4% |
| 22 | Thailand | USD 6.5 mn | 0.5% | USD 12 mn | 6.3% |
| 23 | Indonesia | USD 6.1 mn | 0.5% | USD 11 mn | 6.2% |
| 24 | Egypt | USD 5.7 mn | 0.4% | USD 11 mn | 6.3% |
| 25 | Switzerland | USD 5.4 mn | 0.4% | USD 7.0 mn | 2.6% |
| Rest of world | USD 79 mn | 5.8% | USD 114 mn | 3.7% |
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
Competitive landscape
Group 1: Global leaders
- BD
- Teleflex
- Coloplast
- B. Braun
Group 2: Regional and specialist players
- Medline
- Cardinal Health
- ConvaTec
- Hollister
- Cook Medical
- Pennine Healthcare
- Romsons
- Poly Medicure
- Bicakcilar
- Vygon
Group 3: Emerging and niche players
- Well Lead Medical
- Poiesis Medical
- Amsino
- Degania Silicone
- Sewoon Medical
- Zhanjiang Star Enterprise
Research methodology
Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the urethral balloon catheters market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.
The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 4.3% is calculated from the resulting values.
The market is divided by material, by end use, by catheter, by size, by buyer. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.
Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.
Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.
Frequently asked questions
How big is the urethral balloon catheters market?
The global urethral balloon catheters market is estimated at USD 1.3 bn in 2025 and USD 1.4 bn in 2026.
How fast will the urethral balloon catheters market grow?
It is forecast to reach USD 2.1 bn by 2036, a compound annual growth rate of 4.3% from 2026, an increase of USD 711 mn.
Which country is the largest market for urethral balloon catheters?
United States is the largest market by revenue at USD 408 mn in 2026, 30.0% of the global total. The three largest countries together hold 50.0%.
Which country is growing fastest?
Among the ten largest markets, India is growing fastest at 7.9% a year from 2026 to 2036.
Which urethral balloon catheters segment is largest?
In the by material split, Pure silicone is the largest segment with 40.0% of 2026 revenue.
Who are the leading urethral balloon catheters companies?
Global leaders include BD, Teleflex, Coloplast, B. Braun.
Need the full report?
Request a sample to see the structure, tables and country detail.
Request a free sampleRelated markets in Healthcare
- Proton TherapyUSD 1.4 bn · 8.0% CAGR
- AI-Driven Cardiac DiagnosticsUSD 1.3 bn · 16.0% CAGR
- Eosinophilic EsophagitisUSD 1.4 bn · 12.0% CAGR
- Blister MachineUSD 1.4 bn · 5.5% CAGR
- Organ Preservation & Perfusion ProductsUSD 1.4 bn · 11.0% CAGR
- Frozen Clinical MealUSD 1.3 bn · 3.8% CAGR
- Muscle Stimulation DevicesUSD 1.4 bn · 5.8% CAGR
- Neurosurgery & Spine RobotsUSD 1.4 bn · 12.0% CAGR